Advancing Knowledge,
Improving Patient Outcomes

AcademicCME is a jointly accredited healthcare solutions medical education company designed to impact practice behavior by providing clinicians with multi-format educational resources in various therapeutic areas. Our mission is to improve patient outcomes through practical, customized and comprehensive continuing education.

CE Courses

Advances in Disease Management of Generalized Myasthenia Gravis

Program Overview

This CME program will highlight recent advances in disease management of generalized myasthenia gravis (MG). The expert faculty, led by Dr. Vera Bril, will first outline the pathophysiology of myasthenia gravis, detailing epidemiology, pathogenesis and the case for targeted treatments. Following, current clinical trial data for FcRn inhibitors in MG will be analyzed, including a review of mechanisms ...
View Course
Clinical Update on Anemia of Chronic Kidney Disease: Improving Outcomes for All Patients

Program Overview

Anemia is a common complication in CKD (aCKD) and is associated with a reduced quality of life and increased morbidity and mortality. The mechanisms involved in aCKD are diverse and complex. They include a decrease in endogenous erythropoietin production, absolute and/or functional iron deficiency, and inflammation with increased hepcidin levels, among others. Patients are most commonly managed with ...
View Course
Optimizing Echocardiographic and CMR Assessment in the Diagnosis and Management of Hypertrophic Cardiomyopathy

Program Overview

This CME program, derived from content presented at the European Association of Cardiovascular Imaging Annual Congress EACVI 2023 in Barcelona, Spain, will highlight how to optimize echocardiographic and CMR assessment in the diagnosis and management of hypertrophic cardiomyopathy. In hypertrophic cardiomyopathy, multimodality imaging is crucial to confirm diagnosis, assess for presence and mechanism of left ventricular outflow tract ...
View Course

Case-Based Learning on Optimal Immuno-Oncologic Management of Extensive-Stage Small Cell Lung Cancer

Program Overview

Small-cell lung cancer is a particularly deadly subtype of lung cancer, which accounts for approximately 15% of new lung cancer diagnoses. Unfortunately, nearly 60% of patients with SCLC present first with metastatic or extensive-stage (ES) disease, for whom standard of care therapy for nearly 40 years has been platinum doublet chemotherapy (cisplatin or carboplatin combined with etoposide or ...
View Course

The Advancing Role of PARP Inhibitor Combination Therapies to Improve Outcomes for Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Program Overview

This CME program, derived from content presented at the AACR Annual Meeting 2023 in Orlando, FL, will highlight the advancing role of PARP inhibitor combination therapies to improve outcomes for patients with metastatic castration-resistant prostate cancer (mCRPC). The expert faculty, led by Dr. Alan Tan, will first review the science, mechanism of action, and clinical rationale for PARP-inhibitors ...
View Course

The New Era of Inflammatory Disease Management Through the Application of Biosimilar Therapeutics

Program Overview

While biosimilar therapeutics have been widely available for some time for the treatment inflammatory conditions, many pharmacists, managed care professionals, and other healthcare providers have not had a recent opportunity to investigate data showing the interchangeable safety and efficacy alignment between approved biosimilar therapeutics and their less accessible referent medications. In addition to interchangeability, concepts involving extrapolation and ...
View Course

Upcoming Events

Advanced Curriculum for Multiple Sclerosis 2024

February 27th, 2024

ACTRIMS Forum 2024

February 29th – March 2nd, 2024

Georgia Neurological Society Annual Meeting

March 22nd – 23rd, 2024

San Francisco Neurological Society Annual Meeting

March 22nd – 24th, 2024

Leave a Reply

Your email address will not be published. Required fields are marked *